$AMX

Jefferies Names Top Latin America Stocks Led by Assai and YDUQS

Jefferies identified top Latin American stocks: Assai (Buy, R$12.0 PT), YDUQS (Buy, potential Afya merger), and Aeroméxico (Hold, $100M annual buyback plan). Assai shows resilience, YDUQS may gain from merger, and Aeroméxico signals confidence with buybacks.

Original reporting
Published Aug 25, 2026, 7:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AMX
Neutral
low confidence
Mentioned
$AMX
Relevance
6/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AMXNeutralMed
01

Why it matters

Analyst recommendations provide fresh price‑target updates and merger speculation.

02

Market read

The note adds new analyst viewpoints for three Latin American issuers, potentially influencing short‑term trading.

03

What to watch

Currency volatility and local regulatory risks could affect valuations.

Relevance 6/10Novelty 6/10Timing: today

Background

Jefferies released a new Latin America stock pick list covering three companies.

Company-level read

Ticker impact

$AMXNeutralLow confidence
Context

Jefferies noted Aeroméxico's plan to seek shareholder approval for a $100 million annual share‑repurchase program.

Expected impact

limited upside if approved

Evidence & confidence

Proposal is pending and not yet approved.

Market effects

Highlights opportunities in Latin American retail, education and aviation sectors.

May boost investor interest in Brazil and Mexico equities.

Limited to emerging‑market focused funds.

Counterpoint

Merger talks could stall; buyback may be delayed, limiting upside.

Key entities

  • Jefferies

    Investment bank providing the analysis.

Related articles

$AMXMed

Carlos Slim: 'Pemex crisis is Mexico's main problem'

Carlos Slim Helú, Mexico’s richest man, said the Pemex crisis is Mexico’s main problem. He cited falling output, limited investment and about $85bn in debt. Pemex reportedly ended 2025 with ~$2.5bn losses, while the government provides a bailout. Slim also backed Sheinbaum’s economic management, criticized Moody’s sovereign downgrade, and said $5bn in investments are planned, arguing output could rise by ~800,000 bpd with new investment.

$IHSHighAI 9/10

IHS shareholders to vote on MTN buyout proposal

IHS Holding’s board backed MTN Group’s plan to take the telecom tower operator private, according to an SEC Schedule 13E-3 filing. Shareholders will vote at an EGM in London later this year on a $2.2 billion deal to buy all outstanding IHS shares for $8.50 cash each. If approved, IHS will be delisted from the NYSE. MTN affiliates and Oranje-Nassau Développement have support totaling over 40% of votes.

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

$EXCMed

Why Exelon's CFO is stepping into a new strategy role

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.